Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 25, 2008Blood

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

View Full Paper
Ask AI
Bookmark
Share

Authors

WAWing-Yan AuChinese University of Hong Kong
Dennis D. Weisenburger
Dennis D. WeisenburgerStatens Serum InstitutTITanin IntragumtornchaiChulalongkorn University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Au et al. (2008) studied this question.

synapsesocial.com/papers/6a93b8cb06b85605447c0a5bhttps://doi.org/10.1182/blood-2008-10-185256
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities2000 · 381 citations
  2. 2Nonparametric Estimation from Incomplete Observations1958 · 39,539 citations
  3. 3Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study2005 · 615 citations
  4. 4Phase I study of dexamethasone, methotrexate, ifosfamide, l ‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia2008 · 209 citations
  5. 5ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project2008 · 867 citations